Cardiovascular (CV) disease is a common comorbidity of Parkinson's disease (PD). The background incidence rate of CV events in a levodopa-treated PD population was assessed to better understand these comorbidities in the PD population. One objective of the study is to identify a population of prevalent PD patients with incident levodopa use within the years 2004-2010 on the Integrated Health Care Information Services (IHCIS) database. The second objective is to report the incidence of CV events overall and during intervals 0-6, 6-12 and 12-18 months after first prescription of levodopa among all new levodopa users.
Study Type
OBSERVATIONAL
Enrollment
1
levodopa use
Occurrence of CV events during first 6 months
Time frame: 0-6 months after first prescription of levodopa
Occurrence of CV events during second 6 months
Time frame: 6-12 months after first prescription of levodopa
Occurrence of CV events during third 6 months
Time frame: 12-18 months after first prescription of levodopa
Overall occurrence of CV events
Time frame: 0-18 months overall after first prescription of levodopa
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.